Recent Finacing
Recent Raise
Bamboo Therapeutics develops rAAV-based gene therapies for neurological and neuromuscular orphan diseases, advancing a mini‑dystrophin Duchenne program with scaled-up GMP vector manufacturing and preclinical efficacy.
Focus Areas
Recent Investors
Funding round
Investor